Latest News

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Key Insights Tata Steel's estimated fair value is ₹186 based on 2 Stage Free Cash Flow to Equity Current share price of...

It's been a good week for Infosys Limited ( NSE:INFY ) shareholders, because the company has just released its latest...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

BlackRock (BLK) has wrapped up FY 2025 with fourth quarter revenue of US$7.0b and basic EPS of US$7.26, while trailing 12 month figures show revenue of US$24.2b and EPS of US$35.83. Over recent periods, revenue has moved from US$20.4b in the trailing 12 months to Q4 2024 to US$24.2b by Q4 2025, with basic EPS shifting from US$42.45 to US$35.83 over the same comparison window. With trailing net profit margin at 22.9%, down from 31.2% a year earlier, the latest results pair solid top line...

Why the TKMS & Co KGaA teaming move with Cohere matters for investors TKMS & Co KGaA (XTRA:TKMS) is drawing attention after signing a teaming agreement with Cohere to explore advanced AI across the Canadian Patrol Submarine Program, including decision support, training, and secure naval interfaces. The collaboration focuses on research, prototyping, and evaluation activities that are designed to meet Royal Canadian Navy and Government of Canada security and compliance requirements, while...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Chervon Holdings' (HKG:2285) stock is up by a considerable 34% over the past three months. We wonder if and what role...

Mereo BioPharma Group (NasdaqCM:MREO) has come into focus after releasing mixed Phase 3 results for setrusumab in osteogenesis imperfecta, along with a cash runway update to mid-2027 and progress on its alvelestat and vantictumab programs. See our latest analysis for Mereo BioPharma Group. The mixed Phase 3 readout and cash runway update come after a volatile stretch for the stock, with a 7 day share price return of 29.45% following a 30 day share price return decline of 66.67%, and a 1 year...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Sigma Healthcare Limited's ( ASX:SIG ) price-to-earnings (or "P/E") ratio of 62.9x might make it look like a strong...

In the last year, many Many Idea Cloud Holdings Limited ( HKG:6696 ) insiders sold a substantial stake in the company...

While Hangzhou SF Intra-city Industrial Co., Ltd. ( HKG:9699 ) might not have the largest market cap around , it saw a...

Last One MileLtd's (TSE:9252) stock is up by a considerable 29% over the past month. Given the company's impressive...

PEXA Group Limited's ( ASX:PXA ) price-to-sales (or "P/S") ratio of 6.3x may look like a poor investment opportunity...

Key Insights Top Glove Corporation Bhd's significant individual investors ownership suggests that the key decisions are...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Macau E&M Holding fair value estimate is HK$0.25 Current share...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Although Heavy Minerals Limited ( ASX:HVY ) shareholders have enjoyed a great week with the stock up 15%, insiders who...

Wecon Holdings' (HKG:1793) stock is up by a considerable 74% over the past three months. We, however wanted to have a...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...